— Know what they know.
Not Investment Advice
Also trades as: 0JSY.L (LSE) · $vol 0M

LH NYSE

Labcorp Holdings Inc.
1W: +0.6% 1M: -6.3% 3M: -9.4% YTD: +1.8% 1Y: +2.7% 3Y: +41.5% 5Y: +13.4%
$259.93
+4.18 (+1.63%)
 
Weekly Expected Move ±2.4%
$238 $244 $250 $256 $262
NYSE · Healthcare · Medical - Diagnostics & Research · Alpha Radar Sell · Power 39 · $21.3B mcap · 82M float · 0.757% daily turnover · Short 54% of daily vol

Edge Score

Quantitative competitive moat analysis scoring five pillars of durable advantage — cost leadership, brand intangibles, switching costs, network effects, and efficient scale — using industry percentile rankings on a 0–100 scale.

WEAK EDGE
41.8 / 100
NoneWeakNarrowWide
Primary source: Efficient Scale  ·  ROIC: 8.3%  ·  5Y Avg: 7.0%
Cost Advantage
57
Intangibles
26
Switching Cost
38
Network Effect
35
Scale ★
61
The Edge Score quantifies a company's competitive moat using five pillars: Cost Advantage (20%, operating margin and SG&A efficiency vs industry peers), Intangible Assets (25%, gross margin premium, R&D intensity, brand pricing power), Switching Costs (25%, revenue stability, earnings consistency, customer retention proxied by operating leverage), Network Effects (15%, revenue growth with expanding margins, market share dominance), and Efficient Scale (15%, market concentration, ROIC sustainability). Each pillar is scored 0–100 using industry percentile rankings, then weighted into a composite. Wide ≥ 70, Narrow ≥ 55, Weak ≥ 40, None < 40. LH shows a Weak competitive edge (41.8/100) — limited structural advantages that may face competitive pressure. The primary source of advantage is Efficient Scale. ROIC of 8.3% suggests modest returns relative to capital deployed.

Analyst Insights

Wall Street analyst consensus based on price targets and buy/sell/hold recommendations from institutional research coverage over the trailing 12 months.

Analyst Price Targets
$334
Low
$334
Avg Target
$334
High
Based on 1 analyst since Apr 30, 2026 earnings
Analyst Recommendations
Strong Buy: 0Buy: 26Hold: 9Sell: 0Strong Sell: 0
Rating Summary
ConsensusBuy
Avg Target$311.33
Analysts3
Price Target Change History
DateFirmAnalystOldNewChangeUpside @ CallStock@Call
2026-05-01 Robert W. Baird Eric Coldwell $326 $334 +8 +30.5% $255.97
2026-04-08 Evercore ISI $305 $300 -5 +9.2% $274.72
2026-02-24 Piper Sandler David Westenberg Initiated $300 +5.2% $285.30
2026-02-18 Robert W. Baird $313 $326 +13 +17.8% $276.67
2026-01-14 Robert W. Baird $304 $313 +9 +20.8% $259.18
2025-10-29 UBS Kevin Caliendo $325 $320 -5 +26.1% $253.74
2025-10-29 Robert W. Baird $311 $304 -7 +17.1% $259.69
2025-10-28 Leerink Partners Michael Cherny Initiated $342 +30.7% $261.62
2025-10-17 UBS $305 $325 +20 +13.7% $285.93
2025-10-17 Mizuho Securities Ann Hynes $296 $320 +24 +12.8% $283.71
2025-10-14 Truist Financial $350 $320 -30 +14.9% $278.42
2025-10-03 Evercore ISI $240 $305 +65 +9.1% $279.44
2025-10-02 Barclays $275 $290 +15 +3.9% $279.06
2025-08-25 Robert W. Baird Initiated $311 +12.6% $276.11
2025-07-25 UBS Kevin Caliendo Initiated $305 +15.1% $264.96
2025-06-25 Barclays $271 $275 +4 +6.3% $258.70
2025-02-03 Barclays Luke Sergott $249 $271 +22 +9.3% $247.86
2024-09-24 Evercore ISI Elizabeth Anderson Initiated $240 +6.8% $224.72
2024-09-23 Jefferies Brian Tanquilut Initiated $265 +19.3% $222.22
2024-08-05 Bank of America Securities Michael Ryskin $370 $260 -110 +10.2% $236.00
2024-08-02 Barclays Stephanie Davis Initiated $249 +5.7% $235.67
2024-03-25 Argus Research David Toung $295 $250 -45 +17.6% $212.50
2023-01-06 Morgan Stanley Initiated $303 +25.5% $241.42
2022-11-23 Credit Suisse $312 $305 -7 +28.1% $238.00
2022-07-29 Mizuho Securities Initiated $296 +16.2% $254.72
2022-05-03 Deutsche Bank $294 $265 -29 +8.0% $245.45
2022-05-02 Credit Suisse Initiated $312 +29.8% $240.28
2022-04-25 Wells Fargo Initiated $315 +18.4% $266.12
2022-02-10 Bank of America Securities Derik de Bruin Initiated $370 +33.9% $276.26
2022-01-27 Deutsche Bank Pito Chickering Initiated $294 +8.9% $270.08
2021-07-29 Truist Financial David S Macdonald Initiated $350 +18.2% $296.15
2021-05-19 Argus Research Jasper Hellweg Initiated $295 +9.4% $269.61

Financial Rating

Composite financial health rating (A+ to F) based on discounted cash flow valuation, return on equity, return on assets, debt-to-equity leverage, and relative P/E and P/B multiples.

B+
May 22, 2026
DCF
4
ROE
4
ROA
4
D/E
1
P/E
2
P/B
3
The Financial Rating evaluates six fundamental factors — discounted cash flow (DCF) valuation, return on equity (ROE), return on assets (ROA), debt-to-equity leverage (D/E), and relative price-to-earnings (P/E) and price-to-book (P/B) multiples — each scored 1–5. LH receives an overall rating of B+. Strongest factors: DCF (4/5), ROE (4/5), ROA (4/5). Areas of concern: D/E (1/5), P/E (2/5).
Rating Change History
DateFromTo
2026-02-17 B B+

InsiderStreet Scorecard

Proprietary multi-factor scorecard rating companies across seven fundamental dimensions — profitability, balance sheet strength, earnings quality, growth, value, momentum, and safety — each scored 0–100.

64 Grade B
Profitability
35
Balance Sheet
50
Earnings Quality
75
Growth
62
Value
53
Momentum
89
Safety
80
Cash Flow
62
The InsiderStreet Scorecard rates companies across eight dimensions: Profitability (margins, ROA, ROE), Balance Sheet (leverage, liquidity, coverage), Earnings Quality (accruals, cash conversion), Growth (revenue and earnings trajectory), Value (P/E, P/B, earnings yield, Graham criteria), Momentum (revenue and earnings acceleration), Safety (Altman Z-Score risk adjustment), and Cash Flow (operating cash flow quality, FCF conversion, cash coverage). The overall score blends 35% quality, 35% value, and 30% momentum, with a penalty for distress-zone Altman scores. LH scores highest in Momentum (89/100) and lowest in Profitability (35/100). A grade of B indicates above-average fundamentals with room for improvement in select areas.

Risk & Quality Signals

Academic financial models used by institutional investors to assess bankruptcy risk, earnings manipulation, financial strength, and credit quality.

Altman Z-Score
3.11
Safe Zone
Piotroski F-Score
7/9
Beneish M-Score
-2.56
Unlikely Manipulator
Ohlson O-Score
-8.31
Bankruptcy prob: 0.0%
Low Risk
Credit Rating
A-
Score: 68.2/100
Trend: Improving
Earnings Quality
100/100
OCF/NI: 1.93x
Accruals: -4.7%
The Altman Z-Score (1968) combines five ratios — working capital, retained earnings, EBIT, market value of equity, and sales, all relative to total assets or liabilities — into a single bankruptcy predictor. LH scores 3.11, placing it in the Safe Zone (safe > 2.99, distress < 1.81). Bankruptcy is statistically unlikely within the next two years. The Piotroski F-Score (2000) is a 9-point binary checklist — four profitability tests (positive ROA, positive cash flow, improving ROA, cash flow exceeding net income), three leverage tests (declining debt ratio, improving current ratio, no share dilution), and two efficiency tests (improving gross margin, improving asset turnover). Each pass scores 1 point. LH scores 7/9, signaling strong financial health across all three dimensions. The Beneish M-Score (1999) is an 8-variable model that detects earnings manipulation by comparing year-over-year changes in receivables, gross margins, asset quality, sales growth, depreciation, SG&A, leverage, and accruals. Scores above −1.78 statistically resemble past manipulators. LH's score of -2.56 falls below this threshold, suggesting earnings are unlikely to be manipulated. The Ohlson O-Score (1980) is a 9-variable logistic regression that estimates bankruptcy probability using firm size, leverage, working capital, current ratio, profitability (ROA), cash flow coverage, negative equity flag, consecutive losses flag, and earnings trajectory. The raw score is converted to a probability via logistic transformation. LH's implied 0.0% bankruptcy probability is well within safe territory. Our Credit Rating model scores companies on five weighted components — solvency (30%), earning power (25%), leverage (20%), liquidity (15%), and cash flow quality (10%) — then blends the absolute score with sector and industry peer rankings. For companies with large buyback programs, equity is adjusted by adding back cumulative 5-year repurchases (capped at 80% of FCF generated) to avoid penalizing shareholder-friendly capital allocation. LH receives an estimated rating of A- (score: 68.2/100), with a improving trend. The Earnings Quality score measures how well reported earnings are backed by real cash. It evaluates the operating cash flow to net income ratio (OCF/NI ≥ 1.0 means every dollar of earnings is cash-backed) and the accruals ratio (the gap between earnings and cash flow relative to assets — lower is better). LH's score of 100/100 is high — cash flows strongly support reported earnings.

Valuation

Key valuation multiples comparing the stock's market price to its earnings, revenue, book value, and cash flows. Lower multiples may indicate relative undervaluation versus peers.

P/E
22.72x
PEG
0.75x
P/S
1.51x
P/B
2.45x
P/FCF
15.98x
P/OCF
12.20x
EV/EBITDA
13.87x
EV/Revenue
2.04x
EV/EBIT
20.75x
EV/FCF
20.80x
Earnings Yield
4.26%
FCF Yield
6.26%
Shareholder Yield
3.56%
Graham Number
$163.00
Equity-based multiples (P/E, P/B, P/FCF) compare the stock price to per-share fundamentals and are affected by capital structure. Enterprise value multiples (EV/EBITDA, EV/Revenue, EV/FCF) strip out debt and cash, making them more useful for cross-company comparisons regardless of how companies are financed. The Graham Number — √(22.5 × EPS × Book Value) — is Benjamin Graham's formula for the maximum price a defensive investor should pay. At 22.7x earnings, LH commands a growth premium. Graham's intrinsic value formula yields $163.00 per share, 59% below the current price.

DuPont Decomposition (5-Factor)

The 5-factor DuPont framework breaks Return on Equity into its component drivers — tax efficiency, interest burden, operating profitability, asset utilization, and financial leverage — to reveal what truly drives shareholder returns.

Tax Burden
0.817
NI / EBT
×
Interest Burden
0.830
EBT / EBIT
×
EBIT Margin
0.098
EBIT / Rev
×
Asset Turnover
0.769
Rev / Assets
×
Equity Multiplier
2.206
Assets / Equity
=
ROE
11.3%
The 5-factor DuPont identity decomposes ROE as: Tax Burden × Interest Burden × EBIT Margin × Asset Turnover × Equity Multiplier = ROE. This reveals whether returns are driven by operating performance, financial leverage, or tax efficiency — three very different sources of profitability. LH's ROE of 11.3% is driven by Asset Turnover (0.769), indicating efficient use of assets to generate revenue.

Graham-Dodd Adjusted Valuation

Our adaptation of Graham's growth formula (Fair P/E = 8.5 + 2g) from The Intelligent Investor. The classic version relies on analyst growth projections, which can be unreliable. This adjusted model substitutes the company's realized 3-year EPS CAGR — a backward-looking, verifiable measure of actual earnings power — grounding the valuation in demonstrated performance rather than forecasts.

Adj. Growth Rate
0.34%
Fair P/E
9.19x
Intrinsic Value
$104.36
Price/Value
2.56x
Margin of Safety
-155.66%
Premium
155.66%
Assessment
Undervalued
Graham's classic formula uses analyst-projected growth to estimate a fair P/E (8.5 + 2g). Our adjusted version replaces that projection with LH's realized 0.3% 3-year EPS CAGR — what the company actually delivered, not what analysts hope for. At an intrinsic value of $104.36, LH appears undervalued with a -156% margin of safety. The adjusted fair P/E of 9.2x compares to the current market P/E of 22.7x.

Profitability Trends

Historical profitability ratios tracking how efficiently the company converts revenue into returns for shareholders over time.

Leverage & Solvency Trends

Debt and liquidity metrics showing the company's financial leverage and ability to meet short-term and long-term obligations.

Efficiency & Working Capital Trends

Operating efficiency metrics measuring how quickly the company converts inventory to sales, collects receivables, and manages its cash conversion cycle.

Growth Trends (YoY %)

Year-over-year growth rates for key financial metrics, showing the trajectory of revenue, earnings, and cash flow generation.

Earnings Stability

R-squared of linear regression measuring how predictably revenue, earnings, and margins follow a trend over the trailing 5 years. 1.0 = perfectly predictable; lower values indicate erratic or cyclical behavior.

Monte Carlo Price Simulation

Geometric Brownian Motion with 1,000 antithetic paths over 1 year, seeded from 1800 days of historical volatility. Percentile bands show the range of statistically plausible outcomes — this is a statistical model, not a forecast.

Current Price
$260.09
Median 1Y
$276.87
5th Pctile
$171.21
95th Pctile
$448.71
Ann. Volatility
29.0%
Analyst Target
$311.33
25th–75th percentile 5th–95th percentile Median path Historical Analyst target

Executive Compensation

C-suite compensation breakdown including salary, stock awards, options, and incentive pay. The CEO-to-employee pay ratio and Gini coefficient measure pay distribution fairness.

C-Suite Compensation

ExecutiveSalaryStockTotal
ADAM H. SCHECHTER
President and Chief Executive Officer
$1,435,000 $11,400,463 $18,339,913
JULIA A. WANG
Executive Vice President and Chief Financial Officer
$737,500 $2,681,239 $5,014,869
MARK S. SCHROEDER
Former Executive Vice President and President, Diagnostics and Chief Operations Officer
$748,461 $2,514,961 $4,787,157
BRIAN J. CAVENEY
Executive Vice President and President, Early Development Research Laboratories and Chief Medical and Scientific Officer
$748,461 $2,304,466 $4,355,923
MEGAN D. BAILEY
Executive Vice President and President, Central Laboratories and International
$568,500 $1,257,480 $2,716,267

CEO Pay Ratio

588:1
CEO-to-Employee Pay Ratio
CEO Total Comp: $18,339,913
Avg Employee Cost (SGA/emp): $31,215
Employees: 71,000

C-Suite Pay Equality (Gini)

CEO Compensation Mix

Workforce & Productivity

Workforce efficiency metrics measuring revenue, profit, and R&D spend per employee — key indicators of operational leverage and human capital productivity.

Employees
71,000
+1.4% YoY
Revenue / Employee
$196,503
Rev: $13,951,700,000
Profit / Employee
$12,345
NI: $876,500,000
SGA / Employee
$31,215
Avg labor cost proxy

Scaling Efficiency

All Ratios & Metrics

Complete fundamental data with up to 20 periods of history, sparkline trends, and current values across 13 categories and 130+ financial metrics.

Profitability
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
ROE 33.9% 32.5% 24.1% 21.3% 20.2% 17.8% 12.6% 9.8% 8.2% 6.5% 4.7% 4.8% 5.0% 4.8% 9.4% 9.2% 9.6% 10.7% 10.5% 11.3% 11.29%
ROA 15.1% 14.5% 11.8% 10.4% 9.8% 8.7% 6.3% 4.9% 4.1% 3.3% 2.3% 2.3% 2.4% 2.4% 4.3% 4.2% 4.3% 4.9% 4.8% 5.1% 5.12%
ROIC 20.6% 19.3% 16.4% 14.6% 13.4% 11.7% 8.1% 6.4% 5.7% 4.8% 3.7% 3.6% 3.8% 3.9% 6.1% 6.2% 6.8% 7.5% 7.8% 8.3% 8.35%
ROCE 24.1% 23.0% 19.0% 16.8% 14.9% 12.4% 9.0% 6.9% 6.1% 5.6% 8.0% 8.2% 8.6% 8.4% 7.8% 7.7% 8.0% 8.9% 8.6% 8.9% 8.91%
Gross Margin 32.9% 34.1% 33.9% 31.6% 32.2% 30.9% 26.4% 28.0% 27.8% 27.8% 27.1% 28.2% 28.8% 27.6% 26.9% 28.3% 29.7% 28.8% 26.2% 26.5% 26.52%
Operating Margin 18.3% 18.9% 18.0% 17.6% 14.7% 13.0% 2.5% 10.9% 8.8% 8.3% -4.0% 10.1% 9.2% 7.7% 6.5% 9.7% 11.2% 11.1% 10.9% 10.9% 10.95%
Net Margin 12.2% 14.5% 13.6% 12.6% 12.3% 12.3% 2.1% 7.0% 6.2% 6.0% -5.5% 7.2% 6.4% 5.2% 4.3% 6.4% 6.7% 7.3% 4.7% 7.9% 7.85%
EBITDA Margin 25.1% 25.7% 23.8% 22.9% 17.6% 17.3% 6.8% 15.3% 13.6% 15.6% 9.7% 15.7% 14.7% 12.9% 12.5% 14.9% 15.1% 15.8% 11.9% 15.8% 15.84%
FCF Margin 17.3% 16.8% 16.4% 11.5% 12.5% 10.8% 11.0% 10.1% 8.5% 7.6% 7.0% 5.3% 6.8% 6.6% 8.4% 8.7% 9.4% 10.0% 8.6% 9.8% 9.78%
OCF Margin 19.6% 19.2% 19.3% 14.6% 16.0% 14.5% 14.6% 13.8% 11.8% 10.9% 10.8% 9.5% 11.1% 10.9% 12.2% 12.4% 12.6% 13.1% 11.8% 12.8% 12.82%
ROE 3Y Avg snapshot only 8.50%
ROE 5Y Avg snapshot only 11.17%
ROA 3Y Avg snapshot only 3.89%
ROIC 3Y Avg snapshot only 4.97%
ROIC Economic snapshot only 8.22%
Cash ROA snapshot only 9.86%
Cash ROIC snapshot only 11.86%
CROIC snapshot only 9.05%
NOPAT Margin snapshot only 9.03%
Pretax Margin snapshot only 8.14%
R&D / Revenue snapshot only 0.00%
SGA / Revenue snapshot only 15.70%
SBC / Revenue snapshot only 0.88%
Valuation
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
P/E Ratio 7.72 8.12 10.43 9.69 8.98 8.73 13.56 16.95 21.54 25.74 45.07 41.84 37.52 42.71 25.60 26.63 28.77 28.02 23.81 23.49 22.721
P/S Ratio 1.36 1.35 1.54 1.28 1.20 1.12 1.30 1.36 1.42 1.33 1.55 1.47 1.35 1.46 1.47 1.48 1.63 1.74 1.50 1.56 1.507
P/B Ratio 2.36 2.38 2.41 1.98 1.74 1.49 1.72 1.68 1.77 1.69 2.39 2.30 2.14 2.36 2.37 2.42 2.73 2.98 2.42 2.57 2.451
P/FCF 7.84 8.08 9.36 11.14 9.59 10.32 11.77 13.43 16.70 17.52 22.21 27.58 19.79 22.06 17.43 16.89 17.41 17.35 17.31 15.98 15.982
P/OCF 6.94 7.04 7.98 8.81 7.47 7.67 8.87 9.85 12.01 12.23 14.30 15.54 12.16 13.40 12.04 11.91 12.97 13.29 12.72 12.20 12.197
EV/EBITDA 5.66 5.82 6.94 6.52 6.66 7.04 10.81 13.27 14.68 14.30 14.70 13.98 12.77 14.22 13.72 13.93 14.82 14.77 13.69 13.87 13.873
EV/Revenue 1.69 1.68 1.84 1.59 1.52 1.47 1.74 1.83 1.89 1.79 1.99 1.91 1.78 1.89 1.91 1.91 2.06 2.16 1.97 2.04 2.035
EV/EBIT 6.77 7.14 8.89 8.54 8.67 9.29 15.11 19.37 23.05 23.88 22.35 21.27 19.09 21.09 21.28 21.84 23.07 22.29 20.69 20.75 20.748
EV/FCF 9.75 10.03 11.20 13.81 12.20 13.60 15.79 18.12 22.24 23.62 28.60 35.82 26.14 28.48 22.68 21.89 21.97 21.52 22.84 20.80 20.802
Earnings Yield 12.9% 12.3% 9.6% 10.3% 11.1% 11.5% 7.4% 5.9% 4.6% 3.9% 2.2% 2.4% 2.7% 2.3% 3.9% 3.8% 3.5% 3.6% 4.2% 4.3% 4.26%
FCF Yield 12.8% 12.4% 10.7% 9.0% 10.4% 9.7% 8.5% 7.4% 6.0% 5.7% 4.5% 3.6% 5.1% 4.5% 5.7% 5.9% 5.7% 5.8% 5.8% 6.3% 6.26%
PEG Ratio snapshot only 0.748
EV/OCF snapshot only 15.876
EV/Gross Profit snapshot only 7.326
Acquirers Multiple snapshot only 18.452
Shareholder Yield snapshot only 3.56%
Graham Number snapshot only $163.00
Leverage & Solvency
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Current Ratio 1.66 1.66 1.92 1.92 1.92 1.92 1.50 1.50 1.50 1.50 1.17 1.17 1.17 1.17 1.44 1.44 1.44 1.44 1.42 1.42 1.424
Quick Ratio 1.53 1.53 1.77 1.77 1.77 1.77 1.35 1.35 1.35 1.35 1.02 1.02 1.02 1.02 1.30 1.30 1.30 1.30 1.23 1.23 1.235
Debt/Equity 0.72 0.72 0.62 0.62 0.62 0.62 0.62 0.62 0.62 0.62 0.76 0.76 0.76 0.76 0.90 0.90 0.90 0.90 0.84 0.84 0.836
Net Debt/Equity 0.58 0.58 0.47 0.47 0.47 0.47 0.59 0.59 0.59 0.59 0.69 0.69 0.69 0.69 0.71 0.71 0.71 0.71 0.77 0.77 0.774
Debt/Assets 0.34 0.34 0.31 0.31 0.31 0.31 0.31 0.31 0.31 0.31 0.36 0.36 0.36 0.36 0.40 0.40 0.40 0.40 0.39 0.39 0.392
Debt/EBITDA 1.38 1.41 1.48 1.64 1.86 2.21 2.90 3.62 3.85 3.89 3.61 3.54 3.41 3.53 4.02 4.02 3.89 3.61 3.58 3.47 3.471
Net Debt/EBITDA 1.11 1.14 1.14 1.26 1.42 1.70 2.75 3.44 3.65 3.69 3.28 3.22 3.11 3.21 3.18 3.18 3.08 2.86 3.31 3.21 3.215
Interest Coverage 18.05 17.95 15.74 14.34 15.44 12.50 8.54 6.26 5.27 4.80 5.44 5.65 6.03 5.88 5.61 5.31 5.29 5.73 5.94 6.22 6.217
Equity Multiplier 2.13 2.13 1.98 1.98 1.98 1.98 2.00 2.00 2.00 2.00 2.12 2.12 2.12 2.12 2.28 2.28 2.28 2.28 2.13 2.13 2.134
Cash Ratio snapshot only 0.189
Debt Service Coverage snapshot only 9.297
Cash to Debt snapshot only 0.074
FCF to Debt snapshot only 0.192
Defensive Interval snapshot only 430.2 days
Efficiency & Turnover
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Asset Turnover 0.86 0.87 0.80 0.78 0.74 0.68 0.66 0.62 0.62 0.63 0.66 0.67 0.68 0.69 0.74 0.75 0.77 0.78 0.76 0.77 0.769
Inventory Turnover 30.12 31.14 25.46 25.71 24.27 22.58 21.40 20.31 20.79 21.31 18.61 18.81 19.03 19.39 19.39 19.64 20.02 20.35 19.48 19.87 19.874
Receivables Turnover 8.15 8.23 6.80 6.69 6.30 5.80 6.60 6.18 6.23 6.33 6.58 6.65 6.75 6.87 6.74 6.83 6.99 7.14 6.64 6.73 6.728
Payables Turnover 15.83 16.36 16.66 16.82 15.88 14.77 12.67 12.02 12.30 12.61 10.47 10.58 10.71 10.91 11.02 11.16 11.38 11.57 11.66 11.90 11.900
DSO 45 44 54 55 58 63 55 59 59 58 56 55 54 53 54 53 52 51 55 54 54.3 days
DIO 12 12 14 14 15 16 17 18 18 17 20 19 19 19 19 19 18 18 19 18 18.4 days
DPO 23 22 22 22 23 25 29 30 30 29 35 34 34 33 33 33 32 32 31 31 30.7 days
Cash Conversion Cycle 34 34 46 47 50 54 44 47 46 46 40 40 39 38 40 39 38 38 42 42 41.9 days
Fixed Asset Turnover snapshot only 4.590
Operating Cycle snapshot only 72.6 days
Cash Velocity snapshot only 26.572
Capital Intensity snapshot only 1.300
Growth (YoY)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 42.8% 33.1% 15.3% 3.5% -8.8% -17.0% -17.1% -21.2% -15.6% -6.9% -9.0% -1.6% -1.0% -0.7% 7.0% 7.1% 8.0% 8.3% 7.2% 7.3% 7.34%
Net Income 6.9% 2.3% 52.8% -20.6% -30.9% -36.4% -46.2% -52.3% -58.3% -62.3% -67.3% -56.7% -45.9% -34.1% 78.5% 68.7% 69.8% 96.4% 17.5% 28.8% 28.83%
EPS 6.9% 2.3% 56.1% -16.8% -26.8% -32.0% -41.8% -49.7% -56.5% -60.7% -65.7% -54.5% -42.9% -32.1% 80.0% 69.5% 70.2% 98.0% 18.9% 31.0% 31.01%
FCF 1.4% 82.7% 51.1% -32.8% -34.2% -46.5% -44.4% -30.9% -42.6% -34.6% -42.5% -47.9% -20.4% -13.2% 29.2% 75.3% 48.0% 63.8% 10.0% 20.1% 20.14%
EBITDA 2.5% 1.3% 42.2% -11.6% -30.1% -40.1% -49.7% -55.4% -52.5% -44.1% -23.3% -2.4% 7.5% 5.2% 9.8% 7.5% 7.2% 19.1% 11.1% 14.6% 14.62%
Op. Income 4.2% 1.6% 33.3% -21.8% -36.3% -41.9% -51.5% -57.7% -59.4% -57.7% -54.1% -41.4% -29.7% -20.4% 49.8% 52.2% 59.8% 78.4% 37.9% 43.0% 42.96%
OCF Growth snapshot only 10.98%
Asset Growth snapshot only 0.07%
Equity Growth snapshot only 7.05%
Debt Growth snapshot only -0.95%
Shares Change snapshot only -1.66%
Dividend Growth snapshot only -0.95%
Growth (CAGR)
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue 3Y 13.6% 13.4% 12.5% 12.0% 9.8% 6.5% 5.0% 2.6% 3.2% 1.0% -4.5% -7.0% -8.7% -8.4% -6.9% -6.0% -3.4% 0.0% 1.4% 4.2% 4.20%
Revenue 5Y 11.7% 11.7% 10.8% 10.3% 8.7% 6.4% 5.1% 2.9% 2.5% 2.5% 1.4% 1.8% 2.0% 2.2% 2.4% 2.6% 3.3% 2.0% -0.0% -1.6% -1.58%
EPS 3Y 32.6% 24.8% 37.8% 31.9% 31.9% 36.1% 19.6% 50.4% 36.0% -4.1% -32.2% -42.5% -43.3% -43.4% -29.0% -27.1% -24.9% -19.2% -9.8% 0.3% 0.34%
EPS 5Y 37.2% 35.6% 29.2% 25.3% 24.5% 21.9% 3.3% -1.4% -5.8% -12.3% -12.2% -12.1% -10.6% -7.6% 1.1% 21.3% 19.6% 3.5% -7.8% -15.8% -15.80%
Net Income 3Y 30.5% 22.5% 35.5% 29.4% 29.1% 32.5% 15.8% 46.1% 31.9% -7.8% -35.5% -45.3% -46.2% -46.0% -32.0% -29.7% -27.3% -21.3% -11.8% -2.0% -2.00%
Net Income 5Y 35.7% 33.5% 26.9% 22.7% 21.7% 18.7% 0.2% -4.3% -8.5% -15.2% -15.2% -14.9% -13.4% -10.4% -2.0% 17.9% 16.1% 0.2% -10.8% -18.7% -18.65%
EBITDA 3Y 35.0% 33.2% 30.3% 25.4% 20.5% 13.5% 1.4% 5.1% 5.1% -7.8% -18.1% -27.3% -29.1% -29.3% -24.9% -22.4% -18.2% -11.2% -2.2% 6.4% 6.36%
EBITDA 5Y 22.5% 21.6% 17.7% 15.3% 12.4% 8.8% 2.3% -2.5% -4.0% -4.6% -3.1% -3.0% -2.3% -3.0% -2.6% 4.0% 6.0% -0.3% -7.7% -13.9% -13.87%
Gross Profit 3Y 22.9% 22.8% 21.0% 18.2% 15.8% 11.5% 7.4% 4.6% 4.3% -3.2% -12.1% -16.3% -17.9% -16.8% -13.6% -11.3% -8.4% -4.1% -0.8% 2.5% 2.51%
Gross Profit 5Y 15.3% 14.5% 12.1% 10.4% 8.8% 5.9% 3.1% 1.2% 0.8% 1.1% 1.2% 1.4% 1.9% 2.1% 2.2% 2.9% 4.0% 0.2% -4.5% -7.6% -7.56%
Op. Income 3Y 44.1% 40.7% 35.0% 29.2% 26.1% 19.5% 5.9% 14.3% 10.7% -14.2% -33.3% -42.1% -43.4% -42.0% -30.7% -27.7% -23.1% -15.6% -1.8% 8.4% 8.45%
Op. Income 5Y 27.5% 25.3% 19.9% 16.5% 14.7% 10.7% 3.0% -1.8% -5.0% -7.3% -11.4% -11.7% -10.6% -10.5% -4.0% 5.9% 8.8% -2.2% -9.3% -15.8% -15.84%
FCF 3Y 36.9% 41.3% 44.4% 28.0% 35.0% 15.4% 12.2% 5.7% -3.0% -13.9% -21.5% -37.7% -33.0% -32.8% -25.5% -14.2% -12.2% -2.4% -6.5% 3.1% 3.11%
FCF 5Y 27.3% 27.9% 24.5% 12.9% 14.2% 7.2% 5.2% 3.4% -0.6% -0.3% -0.7% -5.5% 2.4% -2.7% 1.0% 1.5% 1.5% -1.9% -7.2% -12.6% -12.63%
OCF 3Y 30.7% 33.6% 35.1% 22.0% 27.4% 13.7% 10.6% 5.1% -2.4% -10.3% -14.9% -27.7% -24.4% -24.2% -20.1% -10.9% -10.9% -3.4% -5.7% 1.8% 1.76%
OCF 5Y 23.0% 23.7% 21.7% 12.6% 14.0% 8.3% 6.0% 4.5% 0.7% 0.8% 0.9% -1.7% 3.7% 0.4% 1.9% 2.0% 1.1% -1.4% -5.1% -10.1% -10.10%
Assets 3Y 6.6% 6.6% 8.0% 8.0% 8.0% 8.0% 3.8% 3.8% 3.8% 3.8% -5.9% -5.9% -5.9% -5.9% -3.4% -3.4% -3.4% -3.4% -3.0% -3.0% -3.00%
Assets 5Y 7.0% 7.0% 7.4% 7.4% 7.4% 7.4% 4.0% 4.0% 4.0% 4.0% 0.7% 0.7% 0.7% 0.7% 0.4% 0.4% 0.4% 0.4% -1.7% -1.7% -1.73%
Equity 3Y 11.5% 11.5% 13.8% 13.8% 13.8% 13.8% 10.1% 10.1% 10.1% 10.1% -5.9% -5.9% -5.9% -5.9% -7.8% -7.8% -7.8% -7.8% -5.1% -5.1% -5.13%
Book Value 3Y 13.3% 13.6% 15.7% 16.0% 16.2% 16.9% 13.7% 13.4% 13.6% 14.6% -1.1% -1.0% -0.9% -1.3% -3.6% -4.4% -4.8% -5.3% -3.0% -2.9% -2.86%
Dividend 3Y 61.8% 30.0% 14.6% 4.1% 3.8% 3.1% 3.0% 2.4% 2.5% 2.3% 1.9% 2.1% 2.07%
Growth Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Revenue Stability 0.69 0.79 0.90 0.87 0.74 0.64 0.59 0.33 0.24 0.17 0.05 0.01 0.00 0.00 0.00 0.01 0.10 0.23 0.04 0.13 0.132
Earnings Stability 0.33 0.43 0.61 0.40 0.36 0.36 0.24 0.08 0.04 0.00 0.00 0.00 0.01 0.04 0.14 0.10 0.12 0.24 0.49 0.66 0.664
Margin Stability 0.86 0.89 0.89 0.87 0.86 0.90 0.90 0.87 0.86 0.88 0.88 0.86 0.85 0.86 0.90 0.92 0.92 0.93 0.89 0.85 0.852
Rev. Growth Consistency 1.00 1.00 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
Earn. Growth Consistency 0.50 1.00 1.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.50 0.50 0.50 0.50 1.00 1.00 1.000
FCF Positive Streak 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1 1
Earnings Persistence 0.50 0.50 0.50 0.92 0.88 0.85 0.82 0.50 0.50 0.50 0.50 0.50 0.82 0.86 0.50 0.50 0.50 0.50 0.93 0.88 0.885
Earnings Smoothness 0.00 0.00 0.58 0.77 0.64 0.55 0.40 0.29 0.18 0.09 0.00 0.21 0.40 0.59 0.44 0.49 0.48 0.35 0.84 0.75 0.748
ROE Trend 0.21 0.18 0.09 0.04 0.02 -0.03 -0.07 -0.14 -0.17 -0.17 -0.13 -0.10 -0.08 -0.06 0.00 0.01 0.03 0.05 0.03 0.04 0.036
Gross Margin Trend 0.11 0.08 0.03 0.00 0.00 -0.02 -0.05 -0.06 -0.08 -0.07 -0.05 -0.03 -0.03 -0.02 -0.01 -0.01 0.00 0.01 0.00 -0.00 -0.000
FCF Margin Trend 0.09 0.06 0.06 -0.02 -0.01 -0.04 -0.03 -0.05 -0.06 -0.06 -0.07 -0.05 -0.04 -0.03 -0.01 0.01 0.02 0.03 0.01 0.03 0.027
Sustainable Growth Rate 33.9% 32.5% 24.1% 21.3% 19.5% 16.5% 10.6% 7.3% 5.6% 4.0% 1.8% 2.0% 2.2% 2.1% 6.3% 6.1% 6.5% 7.7% 7.6% 8.4% 8.41%
Internal Growth Rate 17.8% 17.0% 13.3% 11.6% 10.5% 8.7% 5.6% 3.8% 2.9% 2.0% 0.9% 1.0% 1.1% 1.0% 2.9% 2.9% 3.1% 3.6% 3.6% 4.0% 3.97%
Cash Flow Quality
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
OCF/Net Income 1.11 1.15 1.31 1.10 1.20 1.14 1.53 1.72 1.79 2.10 3.15 2.69 3.08 3.19 2.13 2.24 2.22 2.11 1.87 1.93 1.926
FCF/OCF 0.88 0.87 0.85 0.79 0.78 0.74 0.75 0.73 0.72 0.70 0.64 0.56 0.61 0.61 0.69 0.70 0.75 0.77 0.74 0.76 0.763
FCF/Net Income snapshot only 1.470
OCF/EBITDA snapshot only 0.874
CapEx/Revenue 2.3% 2.5% 2.9% 3.0% 3.5% 3.7% 3.6% 3.7% 3.3% 3.3% 3.9% 4.1% 4.3% 4.3% 3.8% 3.7% 3.2% 3.1% 3.1% 3.0% 3.04%
CapEx/Depreciation snapshot only 0.625
Accruals Ratio -0.02 -0.02 -0.04 -0.01 -0.02 -0.01 -0.03 -0.04 -0.03 -0.04 -0.05 -0.04 -0.05 -0.05 -0.05 -0.05 -0.05 -0.05 -0.04 -0.05 -0.047
Sloan Accruals snapshot only -0.053
Cash Flow Adequacy snapshot only 2.708
Earnings Quality Score snapshot only 1.000
Dividends & Buybacks
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Dividend Yield 0.0% 0.0% 0.0% 0.0% 0.4% 0.9% 1.1% 1.5% 1.4% 1.5% 1.3% 1.4% 1.5% 1.3% 1.3% 1.2% 1.1% 1.0% 1.2% 1.1% 1.11%
Dividend/Share $0.00 $0.00 $0.00 $0.00 $0.72 $1.45 $2.19 $2.92 $2.89 $2.95 $2.99 $2.97 $2.94 $2.89 $2.89 $2.88 $2.88 $2.89 $2.89 $2.90 $2.88
Payout Ratio 0.0% 0.0% 0.0% 0.0% 3.4% 7.5% 15.3% 25.9% 31.0% 38.8% 60.8% 58.1% 55.1% 56.1% 32.6% 33.2% 31.7% 28.2% 27.5% 25.5% 25.52%
FCF Payout Ratio 0.0% 0.0% 0.0% 0.0% 3.6% 8.9% 13.2% 20.6% 24.0% 26.4% 29.9% 38.3% 29.0% 28.9% 22.2% 21.1% 19.2% 17.5% 20.0% 17.4% 17.36%
Total Payout Ratio 13.4% 24.8% 70.8% 76.9% 88.8% 1.1% 1.0% 1.4% 1.2% 2.4% 3.0% 2.9% 3.0% 94.2% 66.1% 67.4% 77.6% 63.3% 78.8% 83.7% 83.73%
Div. Increase Streak 0 0 0 0 1 1 1 0 0 0 0 0 0 0 0 0 0
Chowder Number 2.87 0.96 0.31 -0.02 -0.02 -0.04 -0.03 -0.02 -0.01 -0.00 0.00 0.00 0.001
Buyback Yield 1.7% 3.1% 6.8% 7.9% 9.5% 11.8% 6.4% 6.5% 4.0% 7.7% 5.3% 5.5% 6.5% 0.9% 1.3% 1.3% 1.6% 1.3% 2.2% 2.5% 2.48%
Net Buyback Yield 1.5% 2.9% 6.7% 7.8% 9.4% 11.7% 6.3% 6.4% 3.6% 7.4% 5.0% 5.2% 6.4% 0.7% 1.2% 1.2% 1.5% 1.0% 1.9% 2.2% 2.20%
Total Shareholder Return 1.5% 2.9% 6.7% 7.8% 9.8% 12.5% 7.4% 7.9% 5.1% 8.9% 6.4% 6.6% 7.8% 2.1% 2.4% 2.4% 2.6% 2.0% 3.0% 3.3% 3.29%
DuPont Factors
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Tax Burden (NI/EBT) 0.75 0.75 0.76 0.76 0.81 0.88 0.94 1.01 0.99 0.87 0.73 0.73 0.68 0.69 0.78 0.78 0.78 0.78 0.79 0.82 0.817
Interest Burden (EBT/EBIT) 0.94 0.94 0.94 0.93 0.94 0.92 0.88 0.84 0.81 0.79 0.52 0.54 0.56 0.55 0.82 0.81 0.81 0.83 0.83 0.83 0.830
EBIT Margin 0.25 0.24 0.21 0.19 0.18 0.16 0.12 0.09 0.08 0.08 0.09 0.09 0.09 0.09 0.09 0.09 0.09 0.10 0.10 0.10 0.098
Asset Turnover 0.86 0.87 0.80 0.78 0.74 0.68 0.66 0.62 0.62 0.63 0.66 0.67 0.68 0.69 0.74 0.75 0.77 0.78 0.76 0.77 0.769
Equity Multiplier 2.24 2.24 2.05 2.05 2.05 2.05 1.99 1.99 1.99 1.99 2.05 2.05 2.05 2.05 2.20 2.20 2.20 2.20 2.21 2.21 2.206
Per Share
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
EPS (Diluted TTM) $29.31 $28.45 $24.71 $22.33 $21.47 $19.36 $14.37 $11.24 $9.33 $7.60 $4.92 $5.11 $5.33 $5.16 $8.86 $8.67 $9.08 $10.22 $10.53 $11.36 $11.36
Book Value/Share $96.10 $97.18 $106.79 $109.29 $110.82 $113.27 $113.44 $113.44 $113.44 $116.05 $92.76 $92.98 $93.42 $93.31 $95.63 $95.52 $95.75 $96.20 $103.60 $103.98 $106.26
Tangible Book/Share $-23.18 $-23.44 $-14.77 $-15.12 $-15.33 $-15.67 $9.55 $9.55 $9.55 $9.77 $-18.96 $-19.00 $-19.09 $-19.07 $-21.45 $-21.43 $-21.48 $-21.58 $-21.22 $-21.30 $-21.30
Revenue/Share $166.88 $170.49 $167.58 $168.71 $161.18 $151.55 $150.15 $140.47 $141.71 $147.16 $143.25 $145.22 $148.13 $150.63 $154.50 $156.32 $160.33 $164.46 $167.69 $170.62 $171.86
FCF/Share $28.88 $28.60 $27.54 $19.42 $20.12 $16.38 $16.56 $14.19 $12.03 $11.17 $9.99 $7.76 $10.11 $9.99 $13.02 $13.67 $15.00 $16.50 $14.50 $16.69 $16.82
OCF/Share $32.64 $32.82 $32.32 $24.55 $25.82 $22.05 $21.98 $19.34 $16.74 $15.99 $15.52 $13.77 $16.45 $16.45 $18.83 $19.38 $20.14 $21.55 $19.72 $21.88 $22.04
Cash/Share $13.45 $13.60 $15.31 $15.67 $15.89 $16.24 $3.60 $3.60 $3.60 $3.69 $6.32 $6.34 $6.37 $6.36 $18.04 $18.02 $18.06 $18.14 $6.40 $6.42 $11.92
EBITDA/Share $49.82 $49.30 $44.48 $41.16 $36.88 $31.63 $24.18 $19.38 $18.23 $18.44 $19.43 $19.88 $20.70 $20.01 $21.51 $21.48 $22.24 $24.04 $24.19 $25.03 $25.03
Debt/Share $68.80 $69.58 $65.93 $67.47 $68.42 $69.93 $70.18 $70.18 $70.18 $71.80 $70.13 $70.30 $70.63 $70.55 $86.38 $86.27 $86.48 $86.89 $86.59 $86.90 $86.90
Net Debt/Share $55.35 $55.98 $50.62 $51.81 $52.53 $53.69 $66.58 $66.58 $66.58 $68.11 $63.81 $63.96 $64.26 $64.19 $68.34 $68.26 $68.42 $68.75 $80.19 $80.48 $80.48
Academic Models
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Altman Z-Score 3.114
Altman Z-Prime snapshot only 4.846
Piotroski F-Score 8 8 8 7 6 6 4 4 4 4 5 6 6 5 8 9 9 9 7 7 7
Beneish M-Score -2.22 -2.10 -2.54 -2.45 -2.54 -2.42 -2.81 -2.93 -2.84 -2.87 -2.77 -2.74 -2.81 -2.78 -2.68 -2.70 -2.71 -2.71 -2.54 -2.56 -2.559
Ohlson O-Score snapshot only -8.308
Net-Net WC snapshot only $-69.19
EVA snapshot only $-252331588.64
Credit
Metric Trend Q2'21 Q3'21 Q4'21 Q1'22 Q2'22 Q3'22 Q4'22 Q1'23 Q2'23 Q3'23 Q4'23 Q1'24 Q2'24 Q3'24 Q4'24 Q1'25 Q2'25 Q3'25 Q4'25 Q1'26 Current
Credit Rating snapshot only A-
Credit Score 81.75 81.89 83.26 79.03 80.12 73.46 71.30 66.20 65.66 60.83 62.55 61.39 61.50 61.09 60.74 60.86 62.45 68.48 68.55 68.17 68.171
Credit Grade snapshot only 7
Credit Trend snapshot only 7.311
Implied Spread (bps) snapshot only 175.000
Industry Credit Rank snapshot only 62
Sector Credit Rank snapshot only 65

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms